
Biologically active macromolecules, chitosan and collagen, possess structural and biochemical properties that make them suitable scaffolds for cell-based wound repair. While mesenchymal stem cells (MSCs) support tissue regeneration, their direct injection is invasive and exposes cells to inflammatory and proteolytic stress, whereas topical delivery without structural support results in poor cell retention. To compare these delivery approaches, this study investigated how the macromolecular architecture of a glutaraldehyde-crosslinked chitosan-collagen (C-C) hydrogel influences MSCs behavior and modulates healing outcomes relative to injected MSCs in a rabbit full-thickness skin wound model. The C-C hydrogel exhibited a porous, interconnected, mechanically resilient macromolecular network that supported MSC adhesion, viability, and proliferation. Its rapid swelling within 24h and complete biodegradation by day 16 underscored its transient but bioactive function. Both injected and hydrogel-loaded MSCs significantly enhanced wound repair compared to hydrogel alone and untreated controls, albeit through different mechanisms. Injected MSCs produced a strong and wide early anti-inflammatory effect, accelerating wound contraction and epithelialization. The response corresponded with an early rise and later suppression of Col Iα1 expression, reducing fibrosis and restoring well-organized collagen. In contrast, MSCs-loaded C-C hydrogels supported slower yet sustained repair, with greater collagen density, enhanced elastic fiber remodeling, and more uniform vascular normalization. These wounds exhibited an early Col III peak and persistently low MMP-1 levels, indicating stable extracellular matrix deposition with reduced degradation. In conclusion, the C-C macromolecular network provides a protective, instructive microenvironment favoring long-term matrix stabilization, whereas injected MSCs drive rapid inflammatory resolution and early tissue closure.
Biopolymer-based hydrogels represent promising materials for wound management owing to their regenerative and anti-inflammatory properties. In this study, a seagrass extract-enriched alginate/polyacrylamide hydrogel was fabricated using a free-radical polymerization approach, with ammonium persulfate (APS) and TEMED as the initiator system and N,N′-methylenebisacrylamide (MBA) as the covalent cross-linking agent. Physicochemical characterization by FTIR, XRD, FESEM, and thermal analyses provided evidence for incorporation of the seagrass extract within the hydrogel network. Cytocompatibility assessment using normal human dermal fibroblast (NHDF) cells demonstrated excellent biocompatibility, with cell viability exceeding 90% at 50 µg/mL (p < 0.05). In vivo wound-healing studies in mice revealed accelerated tissue repair, improved collagen formation, and enhanced tissue remodeling in treated wounds. By day 21, the hydrogel-treated group achieved approximately 90% wound closure compared with 68% in untreated controls (p < 0.05). These findings indicate that the seagrass-loaded alginate/PAA hydrogel is a biocompatible and potential wound dressing candidate with significant potential for regenerative medicine applications.
L-Tyrosine is a valuable aromatic amino acid with diverse applications. Although plasmid-based overexpression has markedly improved L-tyrosine production, the dependence on antibiotic selection and genetic instability under nonselective conditions limits its industrial applicability. To address these issues, this study employed a multi-level metabolic engineering strategy to enhance the L-tyrosine biosynthetic pathway at the genomic level in Bacillus amyloliquefaciens. First, an expression cassette containing the mutant prephenate dehydrogenase (TyrAI309A/E330V) was inserted into the genome of the wild-type strain Z1. When the copy number reached three (strain Z4), L-tyrosine production reached 437.43 mg/L. Subsequently, the mutant DAHP synthase (AroAR27A/K38A) was integrated, and the resulting two-copy strain Z7 increased L-tyrosine production to 591.29 mg/L. Systematic identification of rate-limiting steps showed that most pathway genes enhanced production to varying extents. A promoter in situ replacement strategy was then applied to construct strain Z21, which further increased the titer to 813.01 mg/L. Finally, by optimizing precursor supply, the engineered strain Z32 reached an L-tyrosine titer of 1079.94 mg/L. Overall, this plasmid-free and antibiotic-independent platform offers a promising strategy for stable biosynthesis of L-tyrosine and other aromatic amino acids in microbial cell factories.